Addressing COVID-19 Concerns in Pregnant Women With Rheumatic Diseases
In this interview, Jane E Salmon, MD, provides insight into the risk for COVID-19 in pregnant women with rheumatic diseases.
All articles by Meghna Rao
Case Report: Autoimmune Encephalitis in Patient With Crohn Disease and Ankylosing Spondylitis Receiving Infliximab
In this case study presented at ACTRIMS 2020, researchers reported on data from a patient with Crohn disease and ankylosing spondylitis who developed autoimmune encephalitis while receiving infliximab.
Anifrolumab Superior to Placebo in Moderate to Severe Systemic Lupus Erythematosus
Although the first phase 3 trial of anifrolumab did not meet its primary end point, other study end points that were met suggested a clinical benefit for the monoclonal antibody in systemic lupus erythematosus.
Patient-Reported Outcomes: Unmet Needs, Dissatisfaction With Current Treatment in Rheumatoid Arthritis
Dr Jeffrey Curtis discusses the web-based survey that identified unmet needs perceived by patients with rheumatoid arthritis.
IL-41 Levels Elevated in Synovium of Patients With Psoriatic Arthritis
Researchers investigated the protein expression of interleukin (IL)-41 in the synovial tissue of patients with psoriatic arthritis, rheumatoid arthritis, and osteoarthritis and evaluated the production of IL-41 from the enthesis.
Less Stringent SLE Remission Definitions May Be Insufficiently Distinct From LLDAS
Researchers assessed the attainability and effect of the Definitions of Remission in Systemic Lupus Erythematosus (SLE) compared with the lupus low disease activity state in patients with SLE.
Chronic Kidney Disease Progression, Recovery Common in Patients With Gout Using Urate-Lowering Drugs
Researchers investigated the association between exposure to urate-lowering drugs and the progression and recovery of chronic kidney disease in patients with gout.
Canagliflozin May Reduce Gout-Related Adverse Events, Uric Acid Levels in T2D
Researchers investigated the effects of canagliflozin on serum urate levels and gout in patients with type 2 diabetes.
Addressing Barriers in SLE Diagnosis, Care, and Access to Treatment
Dr Costenbader talks about the contributions made by the Lupus Foundation of America, the barriers affecting outcomes in lupus, and the current state of diagnostic tools and treatments for the disease.
Outcomes of Novel JAK Inhibition for Moderate to Severe Rheumatoid Arthritis
Researchers investigated the long-term safety and effectiveness of peficitinib in the treatment of rheumatoid arthritis.
Next post in Rheumatoid Arthritis
